| Literature DB >> 27170755 |
Jeannette P Staheli1, Michael R Dyen1, Gail H Deutsch2, Ryan S Basom3, Matthew P Fitzgibbon4, Patrick Lewis1, Serge Barcy5,6.
Abstract
UNLABELLED: Human herpesvirus 6A (HHV-6A), HHV-6B, and HHV-7 are classified as roseoloviruses and are highly prevalent in the human population. Roseolovirus reactivation in an immunocompromised host can cause severe pathologies. While the pathogenic potential of HHV-7 is unclear, it can reactivate HHV-6 from latency and thus contributes to severe pathological conditions associated with HHV-6. Because of the ubiquitous nature of roseoloviruses, their roles in such interactions and the resulting pathological consequences have been difficult to study. Furthermore, the lack of a relevant animal model for HHV-7 infection has hindered a better understanding of its contribution to roseolovirus-associated diseases. Using next-generation sequencing analysis, we characterized the unique genome of an uncultured novel pigtailed macaque roseolovirus. Detailed genomic analysis revealed the presence of gene homologs to all 84 known HHV-7 open reading frames. Phylogenetic analysis confirmed that the virus is a macaque homolog of HHV-7, which we have provisionally named Macaca nemestrina herpesvirus 7 (MneHV7). Using high-throughput RNA sequencing, we observed that the salivary gland tissue samples from nine different macaques had distinct MneHV7 gene expression patterns and that the overall number of viral transcripts correlated with viral loads in parotid gland tissue and saliva. Immunohistochemistry staining confirmed that, like HHV-7, MneHV7 exhibits a natural tropism for salivary gland ductal cells. We also observed staining for MneHV7 in peripheral nerve ganglia present in salivary gland tissues, suggesting that HHV-7 may also have a tropism for the peripheral nervous system. Our data demonstrate that MneHV7-infected macaques represent a relevant animal model that may help clarify the causality between roseolovirus reactivation and diseases. IMPORTANCE: Human herpesvirus 6A (HHV-6A), HHV-6B, and HHV-7 are classified as roseoloviruses. We have recently discovered that pigtailed macaques are naturally infected with viral homologs of HHV-6 and HHV-7, which we provisionally named MneHV6 and MneHV7, respectively. In this study, we confirm that MneHV7 is genetically and biologically similar to its human counterpart, HHV-7. We determined the complete unique MneHV7 genome sequence and provide a comprehensive annotation of all genes. We also characterized viral transcription profiles in salivary glands from naturally infected macaques. We show that broad transcriptional activity across most of the viral genome is associated with high viral loads in infected parotid glands and that late viral protein expression is detected in salivary duct cells and peripheral nerve ganglia. Our study provides new insights into the natural behavior of an extremely prevalent virus and establishes a basis for subsequent investigations of the mechanisms that cause HHV-7 reactivation and associated disease.Entities:
Mesh:
Substances:
Year: 2016 PMID: 27170755 PMCID: PMC4944276 DOI: 10.1128/JVI.00651-16
Source DB: PubMed Journal: J Virol ISSN: 0022-538X Impact factor: 5.103
FIG 1Schematic overview of MneHV7 genomic sequences obtained by de novo assembly. (A) A large contiguous sequence (contig) of 122 kb covering most of the unique MneHV7 genome segment and a smaller contig of 6.8 kb with similarity to the HHV-7 U95 and U100 genes were aligned to the HHV-7 (strain RK) reference genome. The gap between the two contigs consisted mostly of the R2 repeat region and was resolved by long-range PCR and Sanger sequencing. (B) An additional contig of 2.4 kb with similarity to HHV-7 end-terminal repeat elements (DR-L/DR-R) was also identified and contained the sequence for the DR1 gene and the first exon as well as most of the intron of the DR6 gene. (C) Sequences at both ends of the 122-kb contig extended into the end-terminal sequences and exhibited strong similarity with the conserved cleavage-packaging motifs, Pac-1 and Pac-2, of human roseoloviruses flanked by the telomeric repeat regions, T1 and T2. The segments containing conserved nucleotide reiterations (highlighted or shaded) for Pac-1 and Pac-2 and flanking telomeric repeat regions (T1, T2) are indicated. All sequences identified to be part of an end-terminal repeat element were duplicated at both genomic ends, on the basis of homology with HHV-7. The MneHV7 unique genome sequence and a segment of the DRs at the genomic termini, including the DR1 gene and the DR6 first exon, are available in GenBank under accession number KU351741.
FIG 2Map of the ORFs identified in the MneHV7 genome. The genomic positions (130-kb unique genome sequence, excluding DRs), lengths, and transcription directions of 84 MneHV7 ORFs (in gray) were identified on the basis of similarity with the annotated HHV-7 RK strain genome using GATU software. ORF boundaries were determined on the basis of the position of start and stop codons and, when applicable, confirmed by the presence of appropriately located poly(A) signals and TATA boxes. Vertical black lines within an ORF indicate predicted splice sites, while the longer-ranged splice between the two protein-coding exons in U60 is indicated with a bar. Internal repeat regions R1 and R2 and the end-terminal direct repeat regions (DR-L [5′], DR-R [3′]) are represented by white rectangles. proc., processing; pack., packaging; RR, ribonucleotide reductase; TCP, triplex capsid protein; DBP, single-stranded DNA-binding protein; MCP, major capsid protein; CPP, capsid portal protein; TA, transactivator.
ORFs predicted from MneHV7 genome sequence with number of exons, coding direction, protein length, and sequence homology to the corresponding ORFs in HHV-7 RK
| ORF | No. of exons | Direction | Length (no. of aa) | % aa sequence identity | Function or homolog | |
|---|---|---|---|---|---|---|
| HHV-7 RK | MneHV7 | |||||
| DR1 | 2 | Forward | 507 | 503 | 47.8 | Unknown |
| DR6 | Exon 1 | Forward | 139 | 109 | 56.0 | Unknown |
| U2 | 1 | Reverse | 359 | 352 | 61.8 | Tegument protein |
| U3 | 1 | Reverse | 384 | 388 | 67.5 | Tegument protein |
| U4 | 1 | Reverse | 542 | 542 | 60.9 | Unknown |
| U7 | 3 | Reverse | 1,232 | 1,228 | 74.8 | Unknown |
| U10 | 1 | Forward | 451 | 448 | 66.4 | Unknown |
| U11 | 1 | Reverse | 755 | 734 | 45.1 | Major tegument protein/capsid binding |
| U12 | 2 | Forward | 333 | 331 | 68.3 | Envelope glycoprotein/intracellular signaling |
| U13 | 1 | Forward | 98 | 95 | 50.0 | Unknown |
| U14 | 1 | Forward | 648 | 630 | 66.9 | Tegument protein |
| U15 | 3 | Reverse | 191 | 190 | 92.7 | Glycoprotein |
| U17 | 2 | Reverse | 330 | 325 | 72.3 | Viral ICA tegument protein/apoptosis |
| U18 | 1 | Reverse | 295 | 299 | 67.9 | Envelope glycoprotein/apoptosis |
| U19 | 1 | Reverse | 325 | 344 | 57.1 | Apoptosis |
| U20 | 1 | Reverse | 391 | 381 | 32.2 | Membrane protein |
| U21 | 1 | Reverse | 430 | 428 | 53.7 | Membrane protein |
| U23 | 1 | Reverse | 171 | 171 | 31.2 | Membrane protein |
| U24 | 1 | Reverse | 82 | 83 | 47.0 | Unknown |
| U24A | 1 | Reverse | 56 | 54 | 53.7 | Unknown |
| U25 | 1 | Reverse | 320 | 319 | 59.6 | Tegument protein |
| U26 | 1 | Reverse | 293 | 295 | 54.9 | Envelope protein/possibly membrane fusion |
| U27 | 1 | Reverse | 364 | 364 | 84.1 | DNA polymerase processivity subunit |
| U28 | 1 | Reverse | 806 | 801 | 64.1 | Ribonucleotide reductase subunit |
| U29 | 1 | Reverse | 286 | 284 | 69.9 | Triplex capsid protein/capsid morphogenesis |
| U30 | 1 | Forward | 938 | 937 | 63.2 | Tegument protein/virion morphogenesis |
| U31 | 1 | Forward | 2,059 | 2,056 | 62.3 | Large tegument protein/capsid transport |
| U32 | 1 | Reverse | 90 | 88 | 79.5 | Capsid protein/capsid morphogenesis |
| U33 | 1 | Reverse | 477 | 471 | 67.4 | Unknown |
| U34 | 1 | Reverse | 258 | 258 | 71.3 | Nuclear egress membrane protein |
| U35 | 1 | Reverse | 104 | 104 | 74.0 | DNA-packaging protein/DNA encapsidation |
| U36 | 1 | Forward | 485 | 483 | 70.1 | DNA-packaging protein/DNA encapsidation |
| U37 | 1 | Forward | 259 | 258 | 76.4 | Nuclear egress lamina protein |
| U38 | 1 | Reverse | 1,013 | 1,012 | 77.3 | DNA polymerase catalytic subunit (pol) |
| U39 | 1 | Reverse | 822 | 817 | 74.0 | gB/cell entry, cell-cell spread |
| U40 | 1 | Reverse | 721 | 716 | 68.2 | DNA-packaging terminase/DNA encapsidation |
| U41 | 1 | Reverse | 1,131 | 1,131 | 82.9 | Single-stranded DNA-binding protein/DNA replication |
| U42 | 1 | Reverse | 516 | 517 | 76.6 | RNA-binding protein/RNA regulation |
| U43 | 1 | Reverse | 861 | 860 | 72.8 | Helicase/primase complex protein |
| U44 | 1 | Forward | 203 | 203 | 65.5 | Tegument protein/virion morphogenesis |
| U45 | 1 | Reverse | 379 | 367 | 60.2 | Deoxyuridine triphosphatase |
| U46 | 1 | Forward | 86 | 81 | 60.0 | Glycoprotein N (gN)/virion morphogenesis |
| U47 | 1 | Reverse | 313 | 382 | 40.2 | Glycoprotein O (gO)/virion morphogenesis |
| U47A | 1 | Forward | 56 | 56 | 54.5 | Envelope glycoprotein 24 |
| U48 | 1 | Reverse | 690 | 691 | 68.5 | Glycoprotein H (gH)/cell entry, cell-cell spread |
| U49 | 1 | Forward | 239 | 230 | 68.3 | Nuclear protein |
| U50 | 1 | Forward | 554 | 553 | 68.3 | Virion packaging protein |
| U51 | 1 | Forward | 294 | 291 | 49.3 | Envelope protein/possibly intracellular signaling |
| U52 | 1 | Reverse | 254 | 255 | 68.4 | Unknown |
| U53 | 1 | Forward | 513 | 500 | 63.4 | Capsid maturation protease |
| U53.5 | 1 | Forward | 230 | 226 | 63.9 | Capsid scaffold protein |
| U54 | 1 | Reverse | 454 | 454 | 71.1 | Tegument protein pp65/immune regulation |
| U55A | 1 | Reverse | 427 | 427 | 49.9 | DNA regulation |
| U55B | 1 | Reverse | 430 | 429 | 50.9 | Unknown |
| U56 | 1 | Reverse | 293 | 293 | 80.5 | Triplex capsid protein/capsid morphogenesis |
| U57 | 1 | Reverse | 1,345 | 1,345 | 80.0 | Major capsid protein/capsid morphogenesis |
| U58 | 1 | Forward | 775 | 763 | 72.1 | Unknown |
| U59 | 1 | Forward | 347 | 343 | 49.4 | Tegument protein |
| U60 | 2 | Reverse | 663 | 663 | 80.4 | DNA-packaging terminase subunit |
| U62 | 1 | Forward | 75 | 72 | 62.5 | Unknown |
| U63 | 1 | Forward | 211 | 207 | 77.7 | Unknown |
| U64 | 1 | Forward | 439 | 439 | 56.5 | Virion-packaging protein |
| U65 | 1 | Forward | 330 | 329 | 74.2 | Capsid binding protein |
| U67 | 1 | Forward | 346 | 346 | 69.9 | Unknown |
| U68 | 1 | Forward | 114 | 114 | 57.0 | Tegument protein/virion morphogenesis |
| U69 | 1 | Forward | 546 | 522 | 67.6 | Serine/threonine protein kinase |
| U70 | 1 | Forward | 480 | 480 | 71.0 | DNase/DNA processing |
| U71 | 1 | Forward | 73 | 78 | 63.0 | Tegument protein |
| U72 | 1 | Reverse | 346 | 345 | 83.5 | Glycoprotein M (gM)/virion morphogenesis |
| U73 | 1 | Forward | 787 | 788 | 69.8 | OBP/DNA replication |
| U74 | 1 | Forward | 659 | 656 | 53.7 | Helicase-primase subunit/DNA replication |
| U75 | 1 | Reverse | 256 | 250 | 54.6 | Tegument protein/virion morphogenesis |
| U76 | 1 | Reverse | 640 | 638 | 73.3 | Capsid portal protein |
| U77 | 1 | Forward | 820 | 820 | 86.2 | Helicase/primase complex protein |
| U79 | 3 | Forward | 506 | 438 | 51.7 | Gene regulation/DNA replication |
| U81 | 1 | Reverse | 254 | 252 | 74.6 | Uracil-DNA glycosylase/DNA repair |
| U82 | 1 | Reverse | 246 | 250 | 66.8 | Glycoprotein L (gL)/cell entry, cell-cell spread |
| U84 | 1 | Reverse | 310 | 308 | 49.7 | Unknown |
| U85 | 1 | Reverse | 280 | 277 | 56.5 | ox-2 homologue (viral OX-2)/immune regulation |
| U86 | 1 | Reverse | 1,205 | 1,157 | 55.8 | Regulatory protein IE-2/gene regulation |
| U90 | 3 | Reverse | 1,199 | 1,008 | 46.0 | Immediate early protein IE-A/gene regulation |
| U91 | 2 | Forward | 153 | 148 | 53.8 | Membrane protein |
| U95 | 1 | Forward | 940 | 951 | 48.3 | Unknown |
| U100 | 10 | Reverse | 603 | 599 | 56.1 | Glycoprotein Q (gQ)/cell entry |
HHV-7 RK, HHV-7 RK strain genome (GenBank accession number NC_001716); MneHV7, MneHV7 genome (GenBank accession number KU351741, this study); aa, amino acids.
Percent amino acid (aa) sequence identity to the corresponding ORFs from the HHV-7 genome (RK strain).
A 2.4-kb contig contained the sequence for both DR1 gene contigs but only for the first exon of the DR6 gene, including some intergenic region.
Predicted splice donor and acceptor sites in MneHV7 genome
| ORF | Exon no. | Sequence | |||
|---|---|---|---|---|---|
| HHV-7 RK acceptor | HHV-7 RK donor | MneHV7 acceptor | MneHV7 donor | ||
| Consensus | YYYYYYYYYYYNY | MAG | YYYYYYYYYYYNY | MAG | |
| DR1 | 1 | TCTCTTCTATCAC | CAT | GTCTTCTCGTCGC | CCG |
| 2 | TTTGCTCTATCGC | None | TTTCGCCTCTCGC | None | |
| DR6 | 1 | CTCCGCGCTGTTC | GCG | GTCTCTCTGTCAC | GCG |
| 2 | TCTACATCCCGGC | None | Not determined | Not determined | |
| U7 | 1 | None | TAA | None | TGA |
| 2 | AAGTTAATTTTGC | TAG | ACCTTTTTTTTTT | CAG | |
| 3 | GATGTTCTTTTTC | None | TGTTTTTTTTAAT | None | |
| U12 | 1 | TTTCTCTTTGATT | CTG | TTTTTCTTTAACT | TGG |
| 2 | AACTTTTTTTCAC | None | TCATATTTCTTAT | None | |
| U15 | 1 | ACTCTTCTTTGTG | ACG | None | ACG |
| 2 | CTCTTTTATTTTC | GCG | TGTTTTTTATTTC | GCG | |
| 3 | TTTTTTTTTCTTT | None | TTGTTTTTTTTTC | None | |
| U17 | 1 | None | TAT | None | TAT |
| 2 | TTGTTGTTTTCAT | None | TGTTTTTTTTTTT | None | |
| U60 | 1 | None | CAC | None | CAC |
| 2 | TCATTTTCTTCTC | None | CATTTTCTTTCCT | None | |
| U97 | 1 | None | AAG | None | AAG |
| 2 | AACATGTTTTCTT | CAG | TTTTTTATGTTTC | CAG | |
| 3 | GTTTCTTTCTTTT | None | TTTCTTTTTTTTT | None | |
| U90 | 1 | GGTTTGTTATTGT | TGA | GGCTTGTTTTTGT | CGA |
| 2 | TAAATTTTATTAC | CAG | AAATCTTTATTGT | CAG | |
| 3 | TTCTTTAAATTCT | None | TCTTTTAAATCCT | None | |
| U91 | 1 | None | CAG | None | CAG |
| 2 | TATTTTTTCTTGT | None | TTATTTTTCTTGT | None | |
| U100 | 1 | AAAATCTCTTCGC | ACA | AAAAATCTTTTGC | ACA |
| 2 | TTTAATTCTTCTA | ATG | TTTTTTTTAAACC | CTG | |
| 3 | GTACCCGCTTATT | AGT | CTTTTCTCAAACC | AGT | |
| 4 | TATTTTTTTTTTT | AAT | TTCTTTTTTTTTT | CAT | |
| 5 | AATTGTGTTTCGC | CAG | CCCTTTTCTCTTA | AAG | |
| 6 | GCTTCTTCATCCT | TTG | TTTTTTAATCCGC | GTG | |
| 7 | TTTTTTTCATACC | ACA | TTTTTATCTCTAC | AAA | |
| 8 | TTTTTTTAATTCT | CAT | TAACTGCGACCAA | TGT | |
| 9 | ATTTCTCGTTCGC | CAG | AAATGTCTTTCTT | CAG | |
| 10 | CATTTTCTCTTTT | None | TTTATTTTTTTTT | None | |
None, no conserved splice acceptor or donor site was found; not determined, no DR6 exon 2 sequence with which to determine the presence of conserved splice sites was available; boldface indicates conserved nucleotides.
In the HHV-7 RK genome, new consensus splice acceptor sites were found near the start codons of the first exons of DR6, U12, and U15. Splice acceptor sites near the start of first exons indicate the possible existence of an upstream noncoding exon.
FIG 3Phylogenetic relationship of MneHV7 with members of the roseolovirus subfamily. The DNA polymerase (DNA pol) amino acid sequences available from 12 human and nonhuman primate roseoloviruses, including MneHV7, were compared using maximum likelihood analysis. GenBank accession numbers are provided beneath the virus designations. The hCMV/HHV5 DNA pol sequence was used as an outgroup. All resolved nodes have posterior probabilities of 1 (chi-square values) and are thus well supported. The scale bar indicates the amino acid sequence divergence among sequences; branch lengths reflect the relative relatedness of the sequence. Known members of the Roseolovirus genus from both provisional lineages (roseolo 1 lineage and roseolo 2 lineage) are shown. HHV, human herpesvirus; Ppan, Pan paniscus or P. bonobo; Ptro, Pan troglodytes (common chimpanzee); Ggor, Gorilla gorilla (lowland gorilla); Mnd, mandrill.
FIG 4Nucleotide sequences of MneHV7 repeat regions R1 and R2. (A) The 9-bp MneHV7 R1 repeats (R1) are shown in the order in which they appear in the sequence, with nucleotides diverging from the consensus motif being highlighted in black. The rate of occurrence of identical motifs repeated multiple times is indicated to the right of the respective motif. (B) The 105-bp MneHV7 R2 consensus (cons.) repeat motif (R2) was aligned with the R2 motifs of HHV-7 (strains RK and JI) and HHV-6B (strain Z29). Identical residues are indicated by dots.
FIG 5Comparison of the DNA-binding domains in the OBP of MneHV7 and different human herpesviruses. Alignment of the carboxy-terminal amino acid sequences of OBPs from MneHV7 and different human herpesviruses, including the human roseoloviruses HHV-7 (GenBank accession number AAC40752), HHV-6A (GenBank accession number CAA58372), and HHV-6B (GenBank accession number AAD49652) and HSV-1 (GenBank accession number X14112), is shown. The boundaries of subdomains A and B are indicated by dashed lines. Conserved amino acids among highly conserved regions (the roseolovirus conserved domain and the herpesvirus OBP domain) within subdomains A and B are highlighted. Amino acid conservation in other positions is shaded gray.
FIG 6Comparison of OBP-binding sites in the oriLyt regions of MneHV7 and human roseoloviruses. The alignment of the OBP-binding domains within the oriLyt regions of the human roseoloviruses and the predicted oriLyt region of the MneHV7 sequence is shown. Conserved nucleotides within box I (OBP-1) and box II (OBP-2) and possible box III binding sites are highlighted, and the roseolovirus consensus sequences for OBP-1 and OBP-2 are indicated below the alignment. The conserved residues of the Oct-1 transcription factor binding site downstream of box II are shaded in gray. The nucleotides contributing to the dyad symmetry across box I, box II, and the AT-rich spacer sequence in the MneHV7 genome are indicated by dashed lines above the MneHV7 sequence.
FIG 7Correlation between MneHV7 viral loads in saliva or salivary glands and viral transcript expression in salivary gland tissues. The MneHV7 viral loads in whole saliva or salivary gland tissues were compared to the total number of VPMM in the corresponding salivary gland tissues. The statistical significance of the correlations was assessed from two-tailed Spearman nonparametric correlations with 95% confidence intervals (for whole saliva, r2 = 0.80 and P = 0.014; for salivary glands, r2 = 0.70 and P = 0.040).
FIG 8Hierarchical cluster analysis of MneHV7 mRNA expression profiles in nine macaque salivary gland tissues. The heat map shows the number of VPMM for each MneHV7 gene in salivary gland tissue from nine different pigtailed macaques. Color intensity represents the number of VPMM for each identified viral gene across all tissue samples. The Manhattan distance matrix was used as the input for generating the dendrograms using the complete linkage-clustering algorithm.
FIG 9Immunohistochemical visualization of MneHV7 infection in macaque salivary glands. Sections from formalin-fixed salivary gland tissues were stained with the KR4 antibody (brown). (A) Salivary gland tissue with a low number of different MneHV7 transcripts detected by RNA-seq is KR4 negative. (B and C) Salivary gland tissues with intermediate (B) or high (C) levels of MneHV7 transcripts reveal specific cytoplasmic and occasionally perinuclear immunoreactivity in duct cells. (D) Positive staining is seen within peripheral nerve ganglia and nerve twigs (arrow).